Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Jubelirer SJ"'
Autor:
Rekha Chaudhary, Christine Lu-Emerson, Tulika Ranjan, Dawit Aregawi, Ricky Chen, Soma Sengupta, Jon Glass, Mark Anderson, Hugh D Moulding, Jubelirer Sj, Jason Schroeder
Publikováno v:
Neuro Oncol
BACKGROUND ChemoID is a cancer stem cell (CSC) cytotoxicity assay for guiding personalized treatment in the clinical trial NCT03632135 using standard-of-care drugs for improving clinical outcomes. The ChemoID assay is a functional test that determine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::430fea5eb9ead229cd0b3dd1de33cc3f
https://europepmc.org/articles/PMC7651697/
https://europepmc.org/articles/PMC7651697/
Publikováno v:
BMJ Case Rep
Merkel cell carcinoma (MCC) is a rare but highly aggressive cutaneous tumour. Most tumours occur in the head and neck, extremities or torso and 36% of them involve the face. Bone marrow involvement in MCC is rare and to our knowledge only nine cases
Publikováno v:
Journal of Clinical Oncology. 36:e18866-e18866
e18866Background: Glioblastoma multiforme (GBM) is the most common and deadliest form of brain tumors in adults; hence, its treatment has been challenging for clinicians and long-term survival rate...
Autor:
Jubelirer Sj, Shaowei Wan
Publikováno v:
Breast cancer research and treatment. 149(1)
Significant age-related variation in chemotherapy use has been observed among elderly patients with metastatic breast cancer (MBC), which may be partly attributable to geographic access factors such as local area physician practice culture and local
Autor:
Richard Hellman, Margaret L. Grunnet, Anne O'Neill, Mark R. Gilbert, Minesh P. Mehta, Jubelirer Sj, Stuart A. Grossman
Publikováno v:
Journal of Neuro-Oncology. 47:145-152
Recent publications support the use of preradiation chemotherapy in the treatment of selected primary brain tumors. In the pediatric population, this treatment strategy often delays radiotherapy and may improve the outcome in patients. This manuscrip
Publikováno v:
American Journal of Hematology. 61:205-208
Platelets play a crucial role in the ischemic complications of percutaneous coronary procedures. The recent availability of C7E3 Fab (Abxiximab or ReoProtrade mark), a chimeric monoclonal antibody Fab fragment directed against the platelet glycoprote
Autor:
Jubelirer Sj
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis. 2:130-136
The incidence of venous thromboembolism (VTE) in patients with primary brain tumors varies be tween 1 and 60%. This variability in incidence is due to study differences in (a) methods of diagnosis of VTE— i.e., diagnosis at autopsy or clinical diag
Autor:
Angela Lambing, Mary G. Hudson, Deanna Mitchell, Angela Tackney, Michael Recht, Erica Johnson, Ray L. Watts, Adam Cuker, JeanMarie M. Zoland, Karen Gutting, Cherys Zimmerman, Ellen White, Glenda Eckert, Gita Massey, Elizabeth Sandon-Kleiboer, Steve Hopewell, Trish Underland, Leslie Witkoff, Angie Riedel, Susan Karp, Cheryl Brower, Kathy McGinty, Charles Sexauer, Glenn Heggie, Joanne Porter, Mark T. Reding, Susumu Inoue, Vivek R. Sharma, Ashley T. Brummel, Marion Koerper, Sarah May, Jonathan M. Ducore, John S. Rogers, Claudia Lupia, C. Wang, Sue Geraghty, Eric H. Kraut, Neiha Dhar, Eric J. Werner, Bertil Glader, Margaret Bosch, Bryce A. Kerlin, Jodi Haar, Roberto Torres, Hassan M. Yaish, Mia Frank, Jay Charles, Jeanne M. Lusher, Dominique Joseph, Philip Kuriakose, Paula L. Bockenstedt, JoAnn A. Ruff, Mary Catherine Noa, Amy E. Lovejoy, Anaadriana Zakarija, Ilene Goldberg, Donna DiMichele, Anne T. Neff, Miriam Granat, Edwin N. Forman, Robin Schwartz, Alice Cohen, Margaret V. Ragni, Brian M. Wicklund, Michael F. Guerrera, Joan Cox Gill, Nadia P. Ewing, Ulrike M. Reiss, Kimo C. Stine, Sue Kovats-Bell, Robin Grant, Tom Coyle, Felicia Kiplinger, Thomas C. Abshire, Desiree Medeiros, Franklin Desposito, Katie Kralovetz, William D. Haire, Paulette Drozdowicz, Michael D. Tarantino, Rosemary P. Holmberg, Angela Stewart, Peter A. Kouides, Jennifer Green, Amy D. Shapiro, Karen Panckeri, Jim Casella, Guy Young, Sylvia Webber, Lee Meadows, Sandy Hibner, Katherine Farrow, Ara Metjian, Cecilia V. Schmidt, Laura Schulz, Robert Mignacca, S. M. Peterson, Sandy Harris, Parvin Saidi, W. Keith Hoots, Hernan Sabio, Diana Mathis, Kenneth D. Herbst, Cathy Glass, Jorge DiPaola, Patricia Fleming, Lisa Palumbo, Richard Lipton, Kristen Jaworski, Valerie Gonzalez, Valerie Crenshaw, Kim Stewart, Craig M. Kessler, Dee Ann Omatsu, Wahid Hanna, Patricia Amerson, Alexis A. Thompson, Afshin Ameri, Helena M. Jacobs, James French, Anne Chambers, Marjorie A. Boyd, George R. Buchanan, Steven W. Pipe, Anita Smith, Jubelirer Sj, Karen Granger, K. A. Schmidt, Suman L. Sood, Becki Berkowitz, Cindy A. Leissinger, Rajiv K. Pruthi, Patricia Ashby, Susan Curoe, Brenda Nielsen, Amy L. Dunn, Mike Lammer, Donna Arden, Carol Diamond, Chris Guelcher, Frances Patterson, Arthur R. Thompson, M. E. Nolte, G. Allen, Alan C. Homans, Marilyn J. Manco-Johnson, Ralph A. Gruppo, Glen Roy, Vlad C. Radulescu, Elizabeth Hanlon, Lynn Menza, Sarah Alexander, J. M. Soucie, Nigel S. Key, Debbie Nelson, Lisa Pullens, Jennifer La Franco, Barbara A. Konkle, Jean Marandola, Jonathan Bernstein, Muriel Herr, Corinthian Bryant
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 15(4)
Type 3 von Willebrand disease (VWD) is a rare bleeding disorder with markedly decreased or absent von Willebrand factor (VWF) protein, accompanied by a parallel decrease in VWF function and factor VIII (FVIII) activity. The goal of this study was to
Autor:
Jubelirer Sj
Publikováno v:
American journal of hematology. 43(1)
The treatment of corticosteroid- and/or splenectomy-refractory immune thrombocytopenic purpura (ITP) includes vinca alkaloids, immunosuppressives, Danazol, intravenous gammaglobulin, and alpha-interferon. However, these treatments have often been ass
Publikováno v:
Blood. 116:2554-2554
Abstract 2554 Background: Millions of patients across the USA received warfarin to prevent and treat thromboembolism each year. Despite its effectiveness warfarin is associated with a risk of bleeding. The Joint Commission has brought attention to th